Insight Molecular Diagnostics Inc. (IMDX)
Automate Your Wheel Strategy on IMDX
With Tiblio's Option Bot, you can configure your own wheel strategy including IMDX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IMDX
- Rev/Share 13.2936
- Book/Share 3.4288
- PB 0.7233
- Debt/Equity 3.0729
- CurrentRatio 4.0352
- ROIC -1.3587
- MktCap 70944356.0
- FreeCF/Share -72.9101
- PFCF -3.0386
- PE -0.0125
- Debt/Assets 0.0668
- DivYield 0
- ROE -28.9807
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
Published: August 25, 2025 by: MCAP MediaWire
Sentiment: Neutral
BOSTON, August 25, 2025 – PRISM MediaWire – The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: IMDX), in an episode on “Democratizing Molecular Diagnostics: Transforming Transplant Success.
Read More
IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics
Published: August 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) (Nasdaq: IMDX), in an episode on “Democratizing Molecular Diagnostics: Transforming Transplant Success.” Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. (iMDx) In the episode, James discussed iMDx's mission, the company's focus on transplant diagnostics, and its strategy to bring testing closer to patients by developing kits that hospitals can run themselves.
Read More
3 Medical Info Systems Stocks to Buy Amid AI Boom and Tariff Risk
Published: July 15, 2025 by: Zacks Investment Research
Sentiment: Positive
AI momentum and rising demand for digital care put Zacks Medical Info Systems industry stocks like VEEV, TXG and IMDX in focus despite new tariff headwinds.
Read More
About Insight Molecular Diagnostics Inc. (IMDX)
- IPO Date 2015-12-30
- Website https://imdxinc.com
- Industry Biotechnology
- CEO Joshua Riggs
- Employees 46